Form 4: H.B. Fuller CFO Reports Insider Stock Holdings & Plan
Insider Ownership Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, filed a Form 4 detailing his beneficial ownership of common stock, phantom units, stock options, and restricted stock units, including a transaction under a 10b5-1 plan.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), reported his beneficial ownership of company securities.
- The filing indicates a transaction was made pursuant to a Rule 10b5-1(c) plan, which allows insiders to set up pre-planned trades.
- As of the filing, Mr. Corkrean directly beneficially owns 54,646 shares of Common Stock.
- He acquired 200.84 phantom units on January 2, 2026, which convert into common stock on a 1-for-1 basis, bringing his total beneficially owned phantom units to 28,047.87.
- Mr. Corkrean holds various employee stock options (Right-to-Buy) with exercise prices ranging from $45.05 to $77.72, and expiration dates extending up to January 27, 2035.
- He also holds Restricted Stock Units (RSUs) that convert into common stock on a 1-for-1 basis, with vesting schedules and expiration dates up to January 27, 2028.
- The phantom units and restricted stock units include amounts acquired pursuant to dividend equivalent features.
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of insider holdings and a pre-planned transaction, indicating executive alignment with shareholder interests through equity ownership.
Positives
- The Executive VP and CFO holds a significant amount of company equity, including common stock, phantom units, stock options, and restricted stock units, aligning his interests with those of shareholders.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy rather than opportunistic trading, which enhances transparency and reduces concerns about insider timing.
Stakeholder Impact
- Shareholders benefit from increased transparency regarding executive equity ownership and trading activities, which can foster confidence in management's alignment with long-term company performance.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Vesting date for 23,696 employee stock options with an exercise price of $50.10. |
| 01/25/2019 | Vesting date for 21,834 employee stock options with an exercise price of $53.57. |
| 01/24/2020 | Vesting date for 41,208 employee stock options with an exercise price of $45.05. |
| 01/24/2021 | Vesting date for 48,309 employee stock options with an exercise price of $48.35. |
| 01/27/2022 | Vesting date for 38,376 employee stock options with an exercise price of $51.89. |
| 01/24/2023 | Vesting date for 21,997 employee stock options with an exercise price of $72.94. |
| 01/24/2024 | Vesting date for 22,312 employee stock options with an exercise price of $68.17 and for 1,302.35 Restricted Stock Units. |
| 01/26/2025 | Vesting date for 24,774 employee stock options with an exercise price of $77.72 and for 2,852.64 Restricted Stock Units. |
| 01/02/2026 | Earliest Transaction Date, acquisition of 200.84 phantom units. |
| 01/05/2026 | Signature date of the reporting person's attorney-in-fact. |
| 01/24/2026 | Expiration date for 1,302.35 Restricted Stock Units. |
| 01/27/2026 | Vesting date for 24,570 employee stock options with an exercise price of $64.28 and for 4,370.58 Restricted Stock Units. |
| 01/26/2027 | Expiration date for 23,696 employee stock options with an exercise price of $50.10 and for 2,852.64 Restricted Stock Units. |
| 01/24/2028 | Expiration date for 21,834 employee stock options with an exercise price of $53.57. |
| 01/27/2028 | Expiration date for 4,370.58 Restricted Stock Units. |
| 01/24/2029 | Expiration date for 41,208 employee stock options with an exercise price of $45.05. |
| 01/24/2030 | Expiration date for 48,309 employee stock options with an exercise price of $48.35. |
| 01/27/2031 | Expiration date for 38,376 employee stock options with an exercise price of $51.89. |
| 01/24/2032 | Expiration date for 21,997 employee stock options with an exercise price of $72.94. |
| 01/24/2033 | Expiration date for 22,312 employee stock options with an exercise price of $68.17. |
| 01/26/2034 | Expiration date for 24,774 employee stock options with an exercise price of $77.72. |
| 01/27/2035 | Expiration date for 24,570 employee stock options with an exercise price of $64.28. |
Recommendation
holdThis Form 4 filing is a routine disclosure of an executive's beneficial ownership and a transaction made under a pre-arranged 10b5-1 plan. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The executive's continued significant equity holdings align management interests with shareholders.
Keywords
H.B. Fuller, FUL, Form 4, Insider Ownership, Executive Compensation, Stock Options, Restricted Stock Units, Phantom Units, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.